Roche does $400M upfront, $15B deal with China's Hansoh
Roche is going all in on Chinese drug discovery and development. The Swiss pharma has inked one of the largest cross-border collaborations of the year, promising $400 million upfront and potentially $15 billion in biobucks ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.